THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR IN ANY OTHER
JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY
APPLICABLE LAW

The current news release constitutes regulated information as defined
in the Belgian Royal Decree of November 14, 2007, regarding the
obligations of issuers of financial instruments that have been
admitted to trading on a regulated market

Brussels, Belgium, October 27, 2009, 17.30 (CET) - UCB SA/NV ("UCB"
or the "Company") announces today that it has successfully completed
the placement of its 5.75% fixed rate bonds through a public offering
in Belgium and Luxembourg. The offer period has been early terminated
on October 27, 2009 at 5:30 pm. The aggregate nominal amount of the
bonds has been set at EUR 750 million.

The net proceeds from the issue of the bonds will be used by UCB for
general corporate purposes and form part of UCB's funding
diversification policy.

The payment date will be November 27, 2009.

BNP Paribas Fortis, ING and KBC Bank act together as lead managers
for this transaction.

The bonds will be listed on the Luxembourg Stock Exchange.

Detlef Thielgen, CFO of UCB, said: "We are very pleased with the
strong support UCB receives in Belgium and Luxembourg and together
with the recent convertible bond issuance, this operation confirms
our ability to access various international Capital Markets."

For further information
Richard Simpson, Investor Relations, UCB
T+32.2.559.9494, richard.simpson@ucb.com

Michael Tuck-Sherman, Investor Relations, UCB
T +32.2.559.9712, michael.tuck-sherman@ucb.com

Nancy Nackaerts, External Communications, UCB
T +32.473.864.414, nancy.nackaerts@ucb.com


About UCB
UCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical company
dedicated to the research, development and commercialization of
innovative medicines with a focus on the fields of central nervous
system and immunology disorders. Employing approximately 10 000
people in over 40 countries, UCB generated revenue of EUR 3.6 billion
in 2008. UCB is listed on Euronext Brussels (symbol: UCB).

Forward looking statement
This press release contains forward-looking statements based on
current plans, estimates and beliefs of management. Such statements
are subject to risks and uncertainties that may cause actual results
to be materially different from those that may be implied by such
forward-looking statements contained in this press release. Important
factors that could result in such differences include: changes in
general economic, business and competitive conditions, effects of
future judicial decisions, changes in regulation, exchange rate
fluctuations and hiring and retention of its employees.

Disclaimer
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR IN ANY OTHER
JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY
APPLICABLE LAW

THE DISTRIBUTION OF THIS ANNOUNCEMENT AND THE OFFER AND SALE OF THE
SECURITIES DESCRIBED IN THIS ANNOUNCEMENT IN CERTAIN JURISDICTIONS
MAY BE RESTRICTED BY LAW. ANY PERSONS READING THIS ANNOUNCEMENT
SHOULD INFORM THEMSELVES OF AND OBSERVE ANY SUCH RESTRICTIONS.

ANY OFFERING AND ANY RELATED FORMAL DOCUMENTATION WILL BE SUBJECT TO
CONDITIONS AND TERMINATION EVENTS, INCLUDING THOSE WHICH ARE
CUSTOMARY FOR SUCH OFFERINGS.  ANY SUCH OFFERING WILL NOT COMPLETE
UNLESS SUCH CONDITIONS ARE FULFILLED AND ANY SUCH TERMINATION EVENTS
HAVE NOT TAKEN PLACE OR THE FAILURE TO FULFILL SUCH A CONDITION OR
THE OCCURRENCE OF A TERMINATION EVENT HAS BEEN WAIVED, IF APPLICABLE

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES IN THE UNITED STATES
OR ANY OTHER JURISDICTION. THE BONDS (AND THE COMPANY'S SHARES) MAY
NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN
EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"). UCB DOES NOT INTEND TO REGISTER ANY
PORTION OF THE PLANNED OFFER IN THE UNITED STATES OR TO CONDUCT AN
OFFERING OF SECURITIES IN THE UNITED STATES. THE OFFERING IS BEING
CONDUCTED OUTSIDE THE UNITED STATES IN ACCORDANCE WITH REGULATION S
UNDER THE SECURITIES ACT.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS WITHIN THE
MEANING OF DIRECTIVE 2003/71/EC OF THE EUROPEAN PARLIAMENT AND THE
COUNCIL OF NOVEMBER 4, 2003 (AS IMPLEMENTED IN EACH MEMBER STATE OF
THE EUROPEAN ECONOMIC AREA, THE "PROSPECTUS DIRECTIVE").

THE DEFINITIVE TERMS OF THE TRANSACTIONS DESCRIBED HEREIN WILL BE
DESCRIBED IN THE PROSPECTUS TO BE PREPARED IN RELATION TO THE
SECURITIES (THE "PROSPECTUS"). INVESTORS SHOULD NOT SUBSCRIBE FOR ANY
SECURITIES REFERRED TO HEREIN EXCEPT ON THE BASIS OF INFORMATION
CONTAINED IN THE FINAL FORM OF THE PROSPECTUS.

THIS ANNOUNCEMENT IS DIRECTED ONLY AT THE FOLLOWING PERSONS IN THE
UNITED KINGDOM: (I) PERSONS WHO HAVE PROFESSIONAL EXPERIENCE IN
MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE
FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER
2005 (THE "ORDER"), (II) PERSONS FALLING WITHIN ARTICLE 49 OF THE
ORDER AND (III) PERSONS TO WHOM IT MAY OTHERWISE LAWFULLY BE
COMMUNICATED (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS
"QUALIFIED PERSONS"). IN THE UNITED KINGDOM, THIS ANNOUNCEMENT IS
ONLY DIRECTED AT QUALIFIED PERSONS AND ANY INVESTMENT OR INVESTMENT
ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS ONLY AVAILABLE TO
QUALIFIED PERSONS OR WILL BE ENGAGED IN ONLY BY QUALIFIED PERSONS.
SOLICITATIONS IN THE UNITED KINGDOM RESULTING FROM THIS ANNOUNCEMENT
WILL BE RESPONDED TO IF THE PERSON CONCERNED IS A QUALIFIED PERSON.
OTHER PERSONS SHOULD NOT RELY OR ACT UPON THIS ANNOUNCEMENT OR ANY OF
ITS CONTENTS.

ANY PURCHASE OF OR APPLICATION FOR BONDS OF THE COMPANY PURSUANT TO
THE OFFERING SHOULD ONLY BE MADE ON THE BASIS OF THE INFORMATION
CONTAINED IN THE PROSPECTUS TO BE ISSUED BY THE ISSUER IN DUE COURSE
IN CONNECTION WITH THE OFFERING.


For the pdf-version of this press release, please click on the link
below:

hugin.info/133973/R/1350405/325875.pdf


This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.